Evaluating the Saving Babies Lives Care Bundle Version 2
Launched by UNIVERSITY OF MANCHESTER · Jun 5, 2024
Trial Information
Current as of April 27, 2025
Completed
Keywords
ClinConnect Summary
In April 2022, NHS England commissioned the University of Manchester to conduct an independent evaluation of the effectiveness of the Saving Babies' Lives Care Bundle Version 2 (SBLCBv2) on reducing perinatal mortality in England. The study was commissioned in two phases.
Phase 1 comprises a national (service) evaluation of the impact of the SBLCBv2 on perinatal mortality rates, associated clinical outcomes, and any unintended consequences using routine data derived from national databases. Phase 2 comprises a qualitative evaluation to further understand the impact on maternity services, w...
Gender
ALL
Eligibility criteria
- Phase 1:
- • All births in England.
- Phase 2:
- Inclusion Criteria:
- • women who have given birth in the last 12 months
- • women who can understand English
- • healthcare professionals involved in delivering the care bundle
- Exclusion Criteria:
- • women who gave birth more than 12 months ago
- • women who cannot understand English
- • women without access to the internet for online survey completion
- • healthcare professionals not involved in delivering the care bundle
About University Of Manchester
The University of Manchester is a leading research institution known for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university leverages its extensive expertise in biomedical research and clinical practice to develop and evaluate new therapies and interventions. The institution is dedicated to improving patient outcomes and public health by conducting rigorous, ethically sound trials that adhere to the highest standards of scientific integrity. Through its state-of-the-art facilities and a robust network of healthcare partnerships, the University of Manchester actively contributes to the global body of medical knowledge and the translation of research findings into clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manchester, , United Kingdom
Patients applied
Trial Officials
Alexander Heazell, Prof
Principal Investigator
The University of Manchester
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported